Humana Inc (HUM) stock
HUMNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3051% above fair value
$450.00+6.32 (+1.42%)
Close on Nov 13, 2026Market cap $54.04BP/E 43.6Yield 0.79%
Humana operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Humana's operating income for the twelve months ending Sep 30, 2026 was $2.38B, down 19.8% year over year. For fiscal 2025 it was $2.70B, up 5.5% from the year before. Over ten years it grew 1.4% a year on average. The highest annual figure on record is $4.99B in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.70B | +5.5% |
| FY2024 | Dec 31, 2024 | $2.56B | -36.2% |
| FY2023 | Dec 31, 2023 | $4.01B | +5.6% |
| FY2022 | Dec 31, 2022 | $3.80B | +20.7% |
| FY2021 | Dec 31, 2021 | $3.15B | -36.9% |
| FY2020 | Dec 31, 2020 | $4.99B | +56.2% |
| FY2019 | Dec 31, 2019 | $3.19B | +3.0% |
| FY2018 | Dec 31, 2018 | $3.10B | -27.3% |
| FY2017 | Dec 31, 2017 | $4.26B | +144.8% |
| FY2016 | Dec 31, 2016 | $1.74B | -25.8% |
| FY2015 | Dec 31, 2015 | $2.35B | -0.6% |
| FY2014 | Dec 31, 2014 | $2.36B | +14.6% |
| FY2013 | Dec 31, 2013 | $2.06B | +2.2% |
| FY2012 | Dec 31, 2012 | $2.02B | -14.0% |
| FY2011 | Dec 31, 2011 | $2.34B | +26.4% |
| FY2010 | Dec 31, 2010 | $1.85B | +8.5% |
| FY2009 | Dec 31, 2009 | $1.71B | +59.2% |
| FY2008 | Dec 31, 2008 | $1.07B | -21.0% |
| FY2007 | Dec 31, 2007 | $1.36B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $75.00M | -81.3% |
| Q2 FY2026 | Jun 30, 2026 | $1.36B | +23.9% |
| Q1 FY2026 | Mar 31, 2026 | $1.75B | -12.9% |
| Q4 FY2025 | Dec 31, 2025 | -$808.00M | – |
| Q3 FY2025 | Sep 30, 2025 | $400.00M | -45.1% |
| Q2 FY2025 | Jun 30, 2025 | $1.10B | -3.8% |
| Q1 FY2025 | Mar 31, 2025 | $2.01B | +62.9% |
| Q4 FY2024 | Dec 31, 2024 | -$543.00M | – |
| Q3 FY2024 | Sep 30, 2024 | $728.00M | -39.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.14B | -20.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.24B | -28.1% |
| Q4 FY2023 | Dec 31, 2023 | -$348.00M | -380.6% |
| Q3 FY2023 | Sep 30, 2023 | $1.21B | +2.9% |
| Q2 FY2023 | Jun 30, 2023 | $1.44B | +18.2% |
| Q1 FY2023 | Mar 31, 2023 | $1.72B | +33.4% |
| Q4 FY2022 | Dec 31, 2022 | $124.00M | +103.3% |
| Q3 FY2022 | Sep 30, 2022 | $1.17B | +86.6% |
| Q2 FY2022 | Jun 30, 2022 | $1.22B | -1.7% |
| Q1 FY2022 | Mar 31, 2022 | $1.29B | +5.4% |
| Q4 FY2021 | Dec 31, 2021 | $61.00M | – |
| Q3 FY2021 | Sep 30, 2021 | $628.00M | -65.6% |
| Q2 FY2021 | Jun 30, 2021 | $1.24B | -49.2% |
| Q1 FY2021 | Mar 31, 2021 | $1.22B | +13.9% |
| Q4 FY2020 | Dec 31, 2020 | -$346.00M | -195.6% |
| Q3 FY2020 | Sep 30, 2020 | $1.82B | +110.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.44B | +118.4% |
| Q1 FY2020 | Mar 31, 2020 | $1.07B | +26.8% |
| Q4 FY2019 | Dec 31, 2019 | $362.00M | -30.0% |
| Q3 FY2019 | Sep 30, 2019 | $868.00M | -9.7% |
| Q2 FY2019 | Jun 30, 2019 | $1.12B | +29.4% |
| Q1 FY2019 | Mar 31, 2019 | $847.00M | +11.4% |
| Q4 FY2018 | Dec 31, 2018 | $517.00M | -8.7% |
| Q3 FY2018 | Sep 30, 2018 | $961.00M | +12.0% |
| Q2 FY2018 | Jun 30, 2018 | $862.00M | -21.6% |
| Q1 FY2018 | Mar 31, 2018 | $760.00M | -56.3% |
| Q4 FY2017 | Dec 31, 2017 | $566.00M | – |
| Q3 FY2017 | Sep 30, 2017 | $858.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.10B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.74B | – |
| Q4 FY2016 | Dec 31, 2016 | -$438.00M | – |
See a number that looks wrong?